Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950134-06-014885
Filing Date
2006-08-04
Accepted
2006-08-04 17:21:31
Documents
8
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-K f22454e10vkza.htm 10-K/A 819757
2 EXHIBIT 21.1 f22454exv21w1.htm EX-21.1 1727
3 EXHIBIT 23.1 f22454exv23w1.htm EX-23.1 2451
4 EXHIBIT 31.1 f22454exv31w1.htm EX-31.1 8543
5 EXHIBIT 31.2 f22454exv31w2.htm EX-31.2 8606
6 EXHIBIT 32.1 f22454exv32w1.htm EX-32.1 3854
7 EXHIBIT 32.2 f22454exv32w2.htm EX-32.2 3998
8 GRAPHIC f22454f2245400.gif GRAPHIC 8428
  Complete submission text file 0000950134-06-014885.txt   862138
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-50577 | Film No.: 061006772
SIC: 2834 Pharmaceutical Preparations